Reported Dec 24, 2014 · Terminated
Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC 64679-735-02), b)…
Wockhardt USA Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wockhardt Usa Inc. · 20 Waterview Blvd., Suite 3 · Parsippany, NJ · 07054
Is this the product you have?
Wockhardt Metoprolol SuccinateExtended-Release Tablets USP50 mga)100-count HDPE bottle (NDC 64679-735-02)b) 4000-count pack (64679-735-08)
- Manufactured byWockhardt Limited, Mumbai, India Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA
- Lot codes and dates
a) Lot # LN10392Exp. 12/14 b) Lot # LN10360Exp. 12/14
- Amount recalled
- 1,118,400 extended release tablets
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wockhardt USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.